|
|
|
01.04.26 - 13:03
|
Merck to Hold First-Quarter 2026 Sales and Earnings Conference Call April 30 (Business Wire)
|
|
|
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2026 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 30. During the call, company executives will provide an overview of Merck's performance for the quarter.
Investors, journalists and the general public may access a live audio webcast of the call via this weblink. A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures and slides highlighting the results, will be available at www.merck.com.
All participants may join the call by dialing (800) 369-3351 (U.S. and Canada Toll-Free) or (517) 308-9448 and using the access code 9818590.
About Merck
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have broug...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26.03.26 - 08:03
|
Merck & Co schlägt schon wieder zu – Blockbuster-Chance (Der Aktionaer)
|
|
|
Der US-amerikanische Konzern Merck & Co will sich erneut im Bereich der Onkologie verstärken. Am gestrigen Mittwoch kündigte das Pharma-Unternehmen die geplante Übernahme von Terns Pharmaceuticals an. Merck & Co hat es dabei auf TERN-701 abgesehen, einem potenziellen Blockbuster zur Behandlung einer bestimmten Form von Leukämie....
|
|
|
|
|
|
|
|
|
25.03.26 - 12:24
|
Merck To Acquire Terns For $53.00/shr (AFX)
|
|
|
KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) and Terns Pharmaceuticals (TERN), a clinical-stage oncology company, announced that the companies have entered into a definitive agreement under which Merck......
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
